Loading
Biofrontera Inc. Stock: price and insider trades · United States
US·Mcap US$12.3M
Biofrontera Inc.: what insiders have been doing
Biofrontera Inc. is a listed company. Filings by its managers are published through SEC (Form 4). 2 insiders have disclosed 4 filings since 18 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought Biofrontera Inc. shares on the open market in the past twelve months. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 4 filings, this issuer sits below that mark.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 20,497 of 23,476 companies
24.8
score / 100
Value2
Quality48
FCF yld-110%
Earn yld-86%
EV/EBITDA·
ROE·
Gross mgn74%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.83
Analyst consensus
2 analysts1.00/5
US$3.00Target US$6.00(+623%)US$9.00
Income statement
RevenueUS$41.7M
Gross profitUS$30.7M74% margin
EBITDA-US$9.2M-22% margin
Net income-US$10.5M-13.8% margin
Valuation
PER (forward)1.9x
P/Book2.0x
Beta0.88
Balance sheet & cash
Market capUS$12.3M
Total debtUS$6.2M
Free Cash Flow-US$13.4M
Debt / Equity126%
Profitability & ownership
ROE-988.4%
ROA-17.5%
% insiders12.0%
% institutions20.7%
Last declaration on 29 July 2026
Declarations11 total
31,250 sharesCommon StockSEC:0001493152-26-035271:0
62,500 sharesCommon StockSEC:0001493152-26-035273:0
137,500 sharesCommon StockSEC:0001493152-26-009257:0
87,500 sharesCommon StockSEC:0001493152-26-009255:0
87,500 sharesCommon StockSEC:0001493152-25-013797:0
137,500 sharesCommon StockSEC:0001493152-25-013799:0
4,771 sharesCommon StockSEC:0001493152-24-021033:0
76,336 sharesCommon StockSEC:0001493152-23-018643:0
95,420 sharesCommon StockSEC:0001493152-23-018641:0
113,379 sharesCommon StockSEC:0001493152-22-026175:0
56,689 sharesCommon StockSEC:0001493152-22-026176:0
11 of 11 declarations
About Biofrontera Inc.
Biofrontera Inc. is a biopharmaceutical company focused on developing treatments for skin diseases. It specializes in innovative solutions for the treatment of skin cancer and other dermatological conditions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
